RyMat Inc
Stuart Silverman
CEO & Founder
(803) 397-8087

RyMat Inc.

Solution Provider to the Pharmaceutical Industry

Jeffrey M. Evans, Ph.D.

Jeffrey Evans, Ph.D. is a pharmaceutical entrepreneur, with a long history of successful drug development. Currently Dr. Evans serves as Business and Corporate Development consultant to NYSARC, Inc.. Prior to joining NYSARC, Dr. Evans was CEO of CWS Packaging, Sr. Director of Integrated Drug Development for CML/AAI, and founder/CEO of Oncoholdings. Dr. Evans is well known in the industry as co-founder and past President of Rondaxe, a leading pharmaceutical consultancy. At Rondaxe, Dr. Evans developed and implemented an innovative business model focused on enabling emerging pharmaceutical companies to  achieve their technical, strategic and financial goals. In this role, Dr. Evans helped dozens of companies realize their development and partnering goals. Companies such as Exelixis, Metabolex, Helsinn, Array, and Endece have benefited significantly from his guidance.

Prior to founding Rondaxe, Dr. Evans enjoyed a career at Bristol-Myers Squibb starting as a Sr. Scientist and culminating as Director of Worldwide Development Sourcing and Planning. Dr. Evans currently serves on the Board of Directors of the Central New York Biotechnology Center, and the Scientific Advisory Board of Novelix Pharmaceuticals. Dr. Evans is a past board member of the Onondaga County Resource Recovery Agency, where he served as Treasurer. Jeff earned his B.Sc. in Chemistry at the State University of New York at Oswego and his Ph.D. in Organic Chemistry at Syracuse University.